Semler Scientific PE Ratio 2013-2025 | SMLR
Current and historical p/e ratio for Semler Scientific (SMLR) from 2013 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Semler Scientific PE ratio as of June 11, 2025 is 9.41.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Semler Scientific PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-12 | 30.74 | 0.00 | |
| 2025-03-31 | 36.20 | $-2.61 | 0.00 |
| 2024-12-31 | 54.00 | $4.91 | 11.00 |
| 2024-09-30 | 23.55 | $2.05 | 11.49 |
| 2024-06-30 | 34.40 | $2.04 | 16.86 |
| 2024-03-31 | 29.21 | $2.79 | 10.47 |
| 2023-12-31 | 44.29 | $2.64 | 16.78 |
| 2023-09-30 | 25.37 | $2.50 | 10.15 |
| 2023-06-30 | 26.24 | $2.25 | 11.66 |
| 2023-03-31 | 26.80 | $2.01 | 13.33 |
| 2022-12-31 | 33.00 | $1.79 | 18.44 |
| 2022-09-30 | 37.55 | $1.56 | 24.07 |
| 2022-06-30 | 28.18 | $1.61 | 17.50 |
| 2022-03-31 | 49.56 | $1.93 | 25.68 |
| 2021-12-31 | 91.65 | $2.12 | 43.23 |
| 2021-09-30 | 125.03 | $2.60 | 48.09 |
| 2021-06-30 | 111.79 | $2.70 | 41.40 |
| 2021-03-31 | 107.50 | $2.00 | 53.75 |
| 2020-12-31 | 94.00 | $1.73 | 54.34 |
| 2020-09-30 | 53.39 | $1.42 | 37.60 |
| 2020-06-30 | 46.00 | $1.77 | 25.99 |
| 2020-03-31 | 39.90 | $1.96 | 20.36 |
| 2019-12-31 | 48.00 | $1.86 | 25.81 |
| 2019-09-30 | 42.00 | $1.68 | 25.00 |
| 2019-06-30 | 43.70 | $0.91 | 48.02 |
| 2019-03-31 | 42.77 | $0.78 | 54.83 |
| 2018-12-31 | 34.40 | $0.65 | 52.92 |
| 2018-09-30 | 35.60 | $0.52 | 68.46 |
| 2018-06-30 | 15.45 | $0.32 | 48.28 |
| 2018-03-31 | 8.75 | $-0.03 | 0.00 |
| 2017-12-31 | 8.00 | $-0.30 | 0.00 |
| 2017-09-30 | 4.25 | $-0.38 | 0.00 |
| 2017-06-30 | 3.10 | $-0.44 | 0.00 |
| 2017-03-31 | 2.50 | $-0.47 | 0.00 |
| 2016-12-31 | 1.45 | $-0.50 | 0.00 |
| 2016-09-30 | 1.70 | $-1.30 | 0.00 |
| 2016-06-30 | 1.37 | $-1.55 | 0.00 |
| 2016-03-31 | 2.06 | $-1.63 | 0.00 |
| 2015-12-31 | 2.56 | $-1.72 | 0.00 |
| 2015-09-30 | 2.90 | $-1.13 | 0.00 |
| 2015-06-30 | 3.23 | $-1.12 | 0.00 |
| 2015-03-31 | 3.50 | $-1.07 | 0.00 |
| 2014-12-31 | 1.96 | $-1.14 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.354B | $0.056B |
| Semler Scientific, Inc. is a medical risk-assessment company. The Company engages in developing, manufacturing, and marketing patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Its products include FloChec (R) which is used in the office setting to allow healthcare providers to measure arterial blood flow in the extremities and is a useful tool for internists and primary care physicians. Semler Scientific, Inc. is headquartered in Portland, Oregon. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $187.241B | 82.01 |
| Thermo Fisher Scientific (TMO) | United States | $156.717B | 18.96 |
| Edwards Lifesciences (EW) | United States | $44.271B | 29.03 |
| Alcon (ALC) | Switzerland | $43.692B | 29.53 |
| IDEXX Laboratories (IDXX) | United States | $42.156B | 48.44 |
| DexCom (DXCM) | United States | $32.541B | 50.30 |
| IQVIA Holdings (IQV) | United States | $27.478B | 15.39 |
| Mettler-Toledo (MTD) | United States | $24.793B | 29.49 |
| STERIS (STE) | Ireland | $23.682B | 26.08 |
| Waters (WAT) | United States | $20.593B | 29.06 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.749B | 0.00 |
| Hologic (HOLX) | United States | $14.391B | 15.64 |
| Sysmex ADR (SSMXY) | Japan | $10.512B | 29.82 |
| Penumbra (PEN) | United States | $9.810B | 76.99 |
| Masimo (MASI) | United States | $9.055B | 33.40 |
| Globus Medical (GMED) | United States | $8.231B | 19.61 |
| Glaukos (GKOS) | United States | $5.665B | 0.00 |
| Teleflex (TFX) | United States | $5.412B | 8.93 |
| TransMedics (TMDX) | United States | $4.833B | 105.06 |
| Integer Holdings (ITGR) | United States | $4.188B | 21.94 |
| PROCEPT BioRobotics (PRCT) | United States | $3.437B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.546B | 15.16 |
| Veracyte (VCYT) | United States | $2.187B | 30.69 |
| Nihon Kohden (NHNKY) | Japan | $2.115B | 24.25 |
| Elekta AB (EKTAY) | Sweden | $1.972B | 17.72 |
| Alphatec Holdings (ATEC) | United States | $1.715B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.435B | 0.00 |
| Artivion (AORT) | United States | $1.241B | 116.20 |
| Pulse Biosciences (PLSE) | United States | $1.125B | 0.00 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.997B | 5.30 |
| Beta Bionics (BBNX) | United States | $0.829B | 0.00 |
| SiBone (SIBN) | United States | $0.802B | 0.00 |
| IRadimed (IRMD) | United States | $0.763B | 38.72 |
| RxSight (RXST) | United States | $0.606B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.570B | 13.36 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.570B | 8.86 |
| Delcath Systems (DCTH) | United States | $0.556B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.537B | 0.00 |
| AxoGen (AXGN) | United States | $0.463B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.446B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.443B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.388B | 0.00 |
| NeuroPace (NPCE) | United States | $0.388B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.360B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.348B | 0.00 |
| 908 Devices (MASS) | United States | $0.261B | 0.00 |
| Neuronetics (STIM) | United States | $0.251B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.13 |
| Sight Sciences (SGHT) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.216B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.185B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.183B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.153B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.138B | 0.00 |
| Accuray (ARAY) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.113B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.084B | 51.00 |
| EnVVeno Medical (NVNO) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.22 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |